A new drug for HIV patients developed by Skolkovo resident Viriom has been included on Russia’s list of vital and essential drugs (VED), meaning it will be available to patients and doctors across Russia under both federally and regionally funded programmes...
Компания « Моторика », резидент биомедицинского кластера Фонда «Сколково», и ПАО «ВымпелКом» (бренд Билайн) анонсировали запуск первого в мире проекта по удаленному мониторингу высокотехнологичных ассистивных устройств. Объединение...
Rusbase, an independent website devoted to technology, business and investment, published a list on Tuesday of the top five most interesting biotech startups in Russia, and all are residents of the Skolkovo Foundation. An ExoAtlet pilot demonstrates the...
ANTWERP, Belgium – Three Skolkovo startups are among the top 50 scale-ups selected to take part in SuperNova , a major new tech fair taking place in Antwerp on September 27-28. SuperNova will take place in various locations surrounding Antwerp's...
Skolkovo resident startup Motorica , which makes prostheses for both children and adults, was awarded a special prize by Russia’s Channel One on Thursday. Konstantin Deblikov (left) tests a prototype adult hand as Motorica CEO Ilya Chekh looks on...
В четверг, накануне Дня медика, который в этом году приходится на 17 июня, в Москве были объявлены лауреаты ежегодной премии в области медицины «Призвание-2018». Специальным призом Первого канала отмечена компания «Моторика», резидент...
Cutting-edge medical systems developed by Skolkovo resident startups will be introduced in the Novgorod region under a cooperation agreement signed on Thursday. The signing followed a meeting between representatives of the regional Health Ministry and Skolkovo...
Это предусмотрено соглашением о сотрудничестве, подписанным председателем правления Фонда «Сколково» Игорем Дроздовым и губернатором Новгородской области Андреем Никитиным. Г-н Дроздов видит большой потенциал взаимодействия и в других направлениях...
Twenty Skolkovo biomed startups are heading to the 2018 BIO International Convention in Boston this week to showcase their innovations at one of the world’s biggest biotech events. Twenty-six Skolkovo resident startups are taking part in BIO 2018...
Компания « Моторика », резидент биомедицинского кластера Фонда «Сколково, объявила о запуске студенческого конкурса в области протезирования и реабилитации Конкурс Motorica HumanX Prize адресован старшеклассникам, студентам и аспирантам...
В Женеве завершился Geneva Health Forum. Это одна из самых представительных мировых площадок для обсуждения инновационных решений в области здравоохранения и медицины. Форум проводится раз в два года, и на этот раз его почетным гостем стала Российская Федерация...
The directors of three Skolkovo startups won awards at two ceremonies this week for their innovative tech developments. Group-IB head Ilya Sachkov at a previous EY awards ceremony. Photo: EY. Ilya Sachkov, head of the cybersecurity company Group...
Insilico Medicine , the parent company of Skolkovo resident biomed startup Insilico , has published a peer-review research paper calling for patients to regain control of their personal medical records, and even to profit from them. The Baltimore-based Insilico...
Seven Skolkovo startups have launched crowdfunding campaigns as they compete against each other in a reality TV show on Russian TV titled “An Idea Worth a Million.” Motorica has made 3D-printed cable-operated prosthetic hands for more than...
Insilico Medicine, the parent company of Skolkovo biomed startup Insilico, has launched a beta 1.0 version of a system that will study aging at the population level and track the efficacy of anti-aging interventions, and could one day help to prevent diseases...
Insilico Medicine, материнская компания сколковского стартапа «Инсилико», договорилась с сотрудничестве с фармгигантом GlaxoSmithKline. Соглашение предусматривает использование последних достижений в области искусственного интеллекта для создания...
UNIM , a resident startup of the Skolkovo Foundation’s biomed cluster that provides remote cancer diagnosis services, has raised investment from Medme, a strategic investor on the digital medicine market. Under the terms of the deal, the details of which...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
Участник «Сколково» ООО Сибнейро стал обладателем диплома «100 лучших изобретений 2016» от Роспатента и Федерального института промышленной собственности (ФИПС). Изобретение - способ предоперационного определения степени злокачественности...
A delegation of more than 40 representatives of South Korea’s LG Electronics visited the Skolkovo innovation centre on Monday to investigate opportunities for cooperation and meet some of Skolkovo’s hi-tech startups. LG Electronics' CTO...
Fourteen Skolkovo biomed startups are currently taking part in the BIO International Convention 2017 in San Diego, California. The four-day convention, which began on June 19, is devoted to the research and development of innovative healthcare, agricultural...
Самая большая за время участия Фонда в конференции Bio группа сколковских компаний отправляется в Сан-Диего. «Сколково» также организует одну из сессий мега-конференции. Bio International Convention 2017 – одно из самых престижных в мире...
The founders and directors of Skolkovo resident startups make up nearly one-third of a list of “ 20 young and promising heroes of tomorrow ” published by the RBC news agency’s magazine on Thursday. Six of the 20 inventors and entrepreneurs...
The Skolkovo Foundation has signed a strategic partnership agreement with the multinational pharmaceuticals giant AstraZeneca to carry out joint scientific research and educational activities in Russia. Irina Panarina, director of AstraZeneca Russia and...
ExoAtlet, a Skolkovo resident startup that makes medical exoskeletons that enable wheelchair-users to walk again, has obtained certification of its product in South Korea, meaning its exoskeletons can be purchased by rehabilitation clinics and individual users...